Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Updated on: May 11,2024 4

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Updated on:May 11,2024 4

Potential overtreatment during life-limiting illness and end of life in older adults

by Gunilla Sonnebring,Karolinska InstitutetCredit: CC0 Public DomainA new thesis from Karolinska Institutet advocates end-of-life care that prioritizes the highest possible quality of life, avoi

Updated on: April 22,2024 13

Potential overtreatment during life-limiting illness and end of life in older adults

by Gunilla Sonnebring,Karolinska InstitutetCredit: CC0 Public DomainA new thesis from Karolinska Institutet advocates end-of-life care that prioritizes the highest possible quality of life, avoi

Updated on:April 22,2024 13

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on: May 25,2024 7

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on:May 25,2024 7

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on: January 08,2024 10

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on:January 08,2024 10

Eliminating common bacterial infection significantly decreases gastric cancer risk

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainWhile it is well known within the medical community that there is a link between the bacteria Helicobacter

Updated on: May 09,2024 5

Eliminating common bacterial infection significantly decreases gastric cancer risk

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainWhile it is well known within the medical community that there is a link between the bacteria Helicobacter

Updated on:May 09,2024 5

Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil

Updated on: January 13,2024 12

Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil

Updated on:January 13,2024 12

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024 15

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024 15

Breast MRI illuminates risk of second breast cancer

byRadiological Society of North AmericaPostoperative surveillance images in a 54-year-old woman who had undergone right breast–conserving surgery and postoperative radiation therapy 2 years prio

Updated on: January 02,2024 9

Breast MRI illuminates risk of second breast cancer

byRadiological Society of North AmericaPostoperative surveillance images in a 54-year-old woman who had undergone right breast–conserving surgery and postoperative radiation therapy 2 years prio

Updated on:January 02,2024 9

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on: February 18,2024 19

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on:February 18,2024 19

Blocking a key immune protein improves radiation therapy for cancer

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainUp to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor re

Updated on: January 22,2024 13

Blocking a key immune protein improves radiation therapy for cancer

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainUp to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor re

Updated on:January 22,2024 13

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat

Updated on: April 07,2024 14

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat

Updated on:April 07,2024 14

New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on: March 12,2024 13

New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on:March 12,2024 13